Childhood Brain Tumor
12
5
6
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
8.3%
1 terminated out of 12 trials
66.7%
-19.8% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (12)
Biomarkers of Brain Injury in Children With Brain Tumors
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
International HIT-MED Registry (I-HIT-MED)
Cognitive Biomarkers in Pediatric Brain Tumor Patients
KEYS to Succeed: Cognitive and Academic Intervention Program for Children and Adolescents Surviving Cancer
The FLaME Cognitive Rehabilitation Study for Childhood Brain Tumour
Precision Medicine for Every Child With Cancer
PRecISion Medicine for Children With Cancer
The Child in Context Intervention Study
Creating a Decision Support System for the Corporate Management of Physical Therapy
Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors
Dietary and Exercise Interventions in Preventing Cardiovascular Disease in Younger Survivors of Leukemia, Lymphoma, or Brain Tumors